# The Effect of Astaxanthin on Oxidative Stress Indices in Patients With Polycystic Ovary Syndrome

> **NCT03991286** · NA · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 48 (actual)

## Conditions studied

- PCOS

## Interventions

- **DIETARY_SUPPLEMENT:** Astaxanthin 8 mg
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03991286
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-20
- **Primary completion:** 2020-11-01
- **Final completion:** 2021-04-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03991286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03991286, "The Effect of Astaxanthin on Oxidative Stress Indices in Patients With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03991286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*